A new review reports that nine people taking semaglutide and tirzepatide — the active ingredient in GLP-1 medications — ...

Explore how chemotherapy causes peripheral neuropathy in 40% of cancer patients. Learn about the risk factors and the need ...

Experts warn Ozempic and Mounjaro may cause sudden, irreversible blindness as patients report vision loss after taking the weight loss drugs.

NeuFit is revolutionizing neurological rehabilitation with its innovative approach that integrates advanced diagnostics and ...

Neuropathy, a condition that affects individuals of all ages but is most common in older adults, often causes pain in the ...

A small percentage of patients taking the extraordinarily popular GLP-1 medications have experienced vision problems, but a ...

Worldwide, cancer chemotherapy is linked to persistent severe peripheral nerve pain (neuropathy) for around 4 in every 10 ...

The global paresthesia treatment market is growing due to rising neurological disorders, tech advancements, and demand for ...

A small percentage have had vision problems, but a direct causal link with the drugs has not been established.